Bitar, Fouad
Zareef, Rana
Ismaeel, Hussain
Abou-Karam, Roukoz
Arabi, Mariam
Bulbul, Ziad
Bitar, Fadi F.
Fahed, Akl C.
Article History
Received: 24 June 2025
Accepted: 14 February 2026
First Online: 23 March 2026
Competing interests
: R.A.K. reports receiving consulting fees from Goodpath. F.F.B. reports being a co-founder of Avigena. A.C.F. reports being a co-founder of Goodpath and Avigena, serving as scientific advisor to MyOme, HeartFlow, and AditumBio, and receiving a research grant from Foresite Labs. The remaining authors declare no competing interests.